RAPIVASE

Welcome to the Brand page for “RAPIVASE”, which is offered here for Cardiovascular agent, a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction;.

Its status is currently believed to be active. Its class is unavailable. “RAPIVASE” is believed to be currently owned by “Boehringer Mannheim Pharmaceuticals Corporation”.


Owner:
BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION
Owner Details
Description:
Cardiovascular agent, a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction;
Categories: CARDIOVASCULAR AGENT